Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Fast Forward

Charles Krauthammer, Conservative Pro-Israel Columnist, Dead At 68

(JTA) — Charles Krauthammer, a fierce defender of Israel and one of the most widely read conservative columnists of his generation, has died.

He was 68. The Pulitizer Prize-winner wrote earlier this month that he had an aggressive form of cancer and had weeks to live. The letter appeared on the websites of both of his employers, Fox News Channel and The Washington Post.

Krauthammer was outspoken for decades in his support of Israel, and was a lacerating critic of the Obama administration. His rejection of the 2015 Iran nuclear deal was influential in galvanizing Jewish organizational opposition to the deal. He regularly made himself available for Jewish events.

Krauthammer also was among a small but unyielding core of conservatives who opposed Donald Trump, even as he closed in on the Republican presidential nomination in 2016 and then the presidency. Krauthammer denounced Trump’s unfiltered rhetoric, which he called “vainglorious.” (Trump called Krauthammer an “overrated clown.”)

Krauthammer, a New York native who was raised in Montreal, was a first-year medical student at Harvard when a diving accident put him in a wheelchair for life. He became a psychiatrist and first emerged in the political sphere as a speechwriter for Vice President Walter Mondale during the Carter administration. Like many hawkish Jewish Democrats, he was soon attracted to the hard-line Cold War postures of President Ronald Reagan.

He won the Pulitzer Prize for Commentary for his Washington Post columns in 1987, and the National Magazine Award for his work at The New Republic in 1984.

He opposed the Oslo accords, primarily distrusting the renunciation of terrorism by the late Palestinian leader Yasser Arafat — a view that seemed vindicated when Arafat embraced the second intifada. Krauthammer also was an outspoken advocate of the Iraq War, scrambling to defend his advocacy when the war went south.

Alyssa Fisher is a news writer at the Forward. Email her at fisher@forward.com, or follow her on Twitter at @alyssalfisher

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.

Now more than ever, American Jews need independent news they can trust, with reporting driven by truth, not ideology. We serve you, not any ideological agenda.

At a time when other newsrooms are closing or cutting back, the Forward has removed its paywall and invested additional resources to report on the ground from Israel and around the U.S. on the impact of the war, rising antisemitism and the protests on college campuses.

Readers like you make it all possible. Support our work by becoming a Forward Member and connect with our journalism and your community.

Make a gift of any size and become a Forward member today. You’ll support our mission to tell the American Jewish story fully and fairly. 

— Rachel Fishman Feddersen, Publisher and CEO

Join our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at editorial@forward.com, subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.

Exit mobile version